» Articles » PMID: 16368934

TGFbeta-mediated FGF Signaling is Crucial for Regulating Cranial Neural Crest Cell Proliferation During Frontal Bone Development

Overview
Journal Development
Specialty Biology
Date 2005 Dec 22
PMID 16368934
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The murine frontal bone derives entirely from the cranial neural crest (CNC) and consists of the calvarial (lateral) aspect that covers the frontal lobe of brain and the orbital aspect that forms the roof of bony orbit. TGFbeta and FGF signaling have important regulatory roles in postnatal calvarial development. Our previous study has demonstrated that conditional inactivation of Tgfbr2 in the neural crest results in severe defects in calvarial development, although the cellular and molecular mechanisms by which TGFbeta signaling regulates the fate of CNC cells during frontal bone development remain unknown. Here, we show that TGFbeta IIR is required for proliferation of osteoprogenitor cells in the CNC-derived frontal bone anlagen. FGF acts downstream of TGFbeta signaling in regulating CNC cell proliferation, and exogenous FGF2 rescues the cell proliferation defect in the frontal primordium of Tgfbr2 mutant. Furthermore, the CNC-derived frontal primordium requires TGFbeta IIR to undergo terminal differentiation. However, this requirement is restricted to the developing calvarial aspect of the frontal bone, whereas the orbital aspect forms despite the ablation of Tgfbr2 gene, implying a differential requirement for TGFbeta signaling during the development of various regions of the frontal bone. This study demonstrates the biological significance of TGFbeta-mediated FGF signaling cascade in regulating frontal bone development, suggests that TGFbeta functions as a morphogen in regulating the fate of the CNC-derived osteoblast and provides a model for investigating abnormal craniofacial development.

Citing Articles

Characteristic craniofacial defects associated with a novel USP9X truncation mutation.

Nagata N, Kurosaka H, Higashi K, Yamaguchi M, Yamamoto S, Inubushi T Hum Genome Var. 2024; 11(1):21.

PMID: 38755172 PMC: 11099082. DOI: 10.1038/s41439-024-00277-w.


Targeting transforming growth factor beta signaling in metastatic osteosarcoma.

Ge R, Huang G J Bone Oncol. 2023; 43:100513.

PMID: 38021074 PMC: 10666000. DOI: 10.1016/j.jbo.2023.100513.


Significance of Premature Vertebral Mineralization in Zebrafish Models in Mechanistic and Pharmaceutical Research on Hereditary Multisystem Diseases.

Van Wynsberghe J, Vanakker O Biomolecules. 2023; 13(11).

PMID: 38002303 PMC: 10669475. DOI: 10.3390/biom13111621.


Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders.

Vlashi R, Zhang X, Wu M, Chen G Genes Dis. 2023; 10(4):1291-1317.

PMID: 37397540 PMC: 10311035. DOI: 10.1016/j.gendis.2022.07.011.


FGF signaling in cranial suture development and related diseases.

Zhao X, Erhardt S, Sung K, Wang J Front Cell Dev Biol. 2023; 11:1112890.

PMID: 37325554 PMC: 10267317. DOI: 10.3389/fcell.2023.1112890.